Search research articles
Contact Us
Filters
Showing results (81-90 of 103) with videos related to
Page
of 11
Sort By:
Harm Reduction Journal
|
July 28, 2017
Harm reduction in name, but not substance: a comparative analysis of current Canadian provincial and territorial policy frameworks
Elaine Hyshka, Jalene Anderson-Baron, Kamagaju Karekezi, et al.
The Journal of Biological Chemistry
|
June 9, 2016
Synthetic Lethal Screen Demonstrates That a JAK2 Inhibitor Suppresses a BCL6-dependent IL10RA/JAK2/STAT3 Pathway in High Grade B-cell Lymphoma
Daniel Beck, Jenny Zobel, Ruth Barber, et al.
The International Journal on Drug Policy
|
April 29, 2017
Canadian harm reduction policies: A comparative content analysis of provincial and territorial documents, 2000-2015
T Cameron Wild, Bernie Pauly, Lynne Belle-Isle, et al.
Plos One
|
May 19, 2021
Public support for harm reduction: A population survey of Canadian adults
T Cameron Wild, Jakob Koziel, Jalene Anderson-Baron, et al.
Pediatric Surgery International
|
August 31, 2017
Enhancing recovery after minimally invasive repair of pectus excavatum
Cristen N Litz, Sandra M Farach, Allison M Fernandez, et al.
Journal of Pediatric Surgery
|
April 6, 2017
Percutaneous ultrasound-guided vs. intraoperative rectus sheath block for pediatric umbilical hernia repair: A randomized clinical trial
Cristen N Litz, Sandra M Farach, Allison M Fernandez, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 27, 2009
Orally active C-6 heteroaryl- and heterocyclyl-substituted imidazo[1,2-a]pyridine acid pump antagonists (APAs)
Nick Bailey, Mark J Bamford, Delphine Brissy, et al.
Gut
|
August 24, 2017
Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer
Irene Yushing Chong, Lauren Aronson, Hanna Bryant, et al.
Cancer Research
|
March 30, 2016
Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast Cancer
Maria Teresa Herrera-Abreu, Marta Palafox, Uzma Asghar, et al.
Scientific Reports
|
January 19, 2019
A novel tankyrase inhibitor, MSC2504877, enhances the effects of clinical CDK4/6 inhibitors
Malini Menon, Richard Elliott, Leandra Bowers, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 103) with videos related to
Sort By:
Page
of 11
Harm Reduction Journal
|
July 28, 2017
Harm reduction in name, but not substance: a comparative analysis of current Canadian provincial and territorial policy frameworks
Elaine Hyshka, Jalene Anderson-Baron, Kamagaju Karekezi, et al.
The Journal of Biological Chemistry
|
June 9, 2016
Synthetic Lethal Screen Demonstrates That a JAK2 Inhibitor Suppresses a BCL6-dependent IL10RA/JAK2/STAT3 Pathway in High Grade B-cell Lymphoma
Daniel Beck, Jenny Zobel, Ruth Barber, et al.
The International Journal on Drug Policy
|
April 29, 2017
Canadian harm reduction policies: A comparative content analysis of provincial and territorial documents, 2000-2015
T Cameron Wild, Bernie Pauly, Lynne Belle-Isle, et al.
Plos One
|
May 19, 2021
Public support for harm reduction: A population survey of Canadian adults
T Cameron Wild, Jakob Koziel, Jalene Anderson-Baron, et al.
Pediatric Surgery International
|
August 31, 2017
Enhancing recovery after minimally invasive repair of pectus excavatum
Cristen N Litz, Sandra M Farach, Allison M Fernandez, et al.
Journal of Pediatric Surgery
|
April 6, 2017
Percutaneous ultrasound-guided vs. intraoperative rectus sheath block for pediatric umbilical hernia repair: A randomized clinical trial
Cristen N Litz, Sandra M Farach, Allison M Fernandez, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 27, 2009
Orally active C-6 heteroaryl- and heterocyclyl-substituted imidazo[1,2-a]pyridine acid pump antagonists (APAs)
Nick Bailey, Mark J Bamford, Delphine Brissy, et al.
Gut
|
August 24, 2017
Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer
Irene Yushing Chong, Lauren Aronson, Hanna Bryant, et al.
Cancer Research
|
March 30, 2016
Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast Cancer
Maria Teresa Herrera-Abreu, Marta Palafox, Uzma Asghar, et al.
Scientific Reports
|
January 19, 2019
A novel tankyrase inhibitor, MSC2504877, enhances the effects of clinical CDK4/6 inhibitors
Malini Menon, Richard Elliott, Leandra Bowers, et al.
Page
of 11